Harmony Biosciences Holdings (HRMY) Other financing activities (2020 - 2026)

Harmony Biosciences Holdings (HRMY) has 7 years of Other financing activities data on file, last reported at $347000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities fell 92.63% year-over-year to $347000.0; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (down 47.29% YoY), and the FY2025 full-year result was $10.2 million, up 56.98% from the prior year.
• Other financing activities slipped to $347000.0 in Q1 2026, from $2.6 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $4.7 million in Q1 2025 to a low of $116000.0 in Q1 2024.
• A 5-year average of $1.8 million and a median of $1.9 million in 2022 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities surged 15591.67% in 2022 and sank 97.03% in 2024, its largest moves.
• Tracing HRMY's Other financing activities over 5 years: stood at $3.6 million in 2022, then sank by 93.63% to $227000.0 in 2023, then soared by 1325.99% to $3.2 million in 2024, then retreated by 18.2% to $2.6 million in 2025, then slumped by 86.9% to $347000.0 in 2026.
• Business Quant data shows HRMY's Other financing activities at $347000.0 in Q1 2026, $2.6 million in Q4 2025, and $754000.0 in Q3 2025.